Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Operating Income: 2011-2024

Historic Operating Income for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to -$64.2 million.

  • Abeona Therapeutics' Operating Income fell 56.52% to -$24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.2 million, marking a year-over-year decrease of 36.97%. This contributed to the annual value of -$64.2 million for FY2024, which is 36.23% down from last year.
  • Latest data reveals that Abeona Therapeutics reported Operating Income of -$64.2 million as of FY2024, which was down 36.23% from -$47.1 million recorded in FY2023.
  • Over the past 5 years, Abeona Therapeutics' Operating Income peaked at -$47.1 million during FY2023, and registered a low of -$89.8 million during FY2021.
  • For the 3-year period, Abeona Therapeutics' Operating Income averaged around -$54.1 million, with its median value being -$50.9 million (2022).
  • Per our database at Business Quant, Abeona Therapeutics' Operating Income soared by 43.32% in 2022 and then crashed by 36.23% in 2024.
  • Yearly analysis of 5 years shows Abeona Therapeutics' Operating Income stood at -$81.4 million in 2020, then fell by 10.34% to -$89.8 million in 2021, then spiked by 43.32% to -$50.9 million in 2022, then climbed by 7.42% to -$47.1 million in 2023, then tumbled by 36.23% to -$64.2 million in 2024.